XML 49 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation Plans (Tables)
12 Months Ended
Apr. 30, 2021
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
    Twelve months ended April 30,  
    2021     2020  
             
Risk-free interest rate     0.6 %     1.7 %
Expected dividend yield     0.0 %     0.0 %
Expected life (in years)     5.5 - 5.8       5.5 - 5.8  
Expected volatility     136.5 %     127.6% - 128.2 %
Schedule of Stock Option Activity
                Weighted  
                Average  
          Weighted     Remaining  
    Shares     Average     Contractual  
    Underlying     Exercise     Term  
    Options     Price     (In Years)  
Outstanding as of April 30, 2020     474,128     $ 3.56       9.4  
Granted     248,876     $ 2.93          
Exercised     (175,500 )   $ 1.05          
Cancelled/forfeited     (30,677 )   $ 7.31          
Outstanding as of April 30, 2021     516,827     $ 3.89       9.0  
Exercisable as of April 30, 2021     248,252     $ 5.07       8.3
Schedule of Non-vested Restricted Stock Activity

A summary of unvested restricted stock under our stock incentive plans is as follows:

 

          Weighted  
    Number     Average Price per  
    of Shares     Share  
             
Issued and unvested at April 30, 2020     13,513     $ 1.48  
Granted     10,000     $ 2.93  
Vested     (13,513 )   $ 1.48  
Cancelled/forfeited     -     $ -  
Issued and unvested at April 30, 2021     10,000     $ 2.93  

Performance Stock Options [Member]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The Company determined these awards contain a market- based condition and estimated the fair value using the Monte Carlo simulation model with the following assumptions:

 

    Twelve months ended April 30,  
    2021     2020  
             
Risk-free interest rate     1.2 %     2.3 %
Expected dividend yield     0.0 %     0.0 %
Expected life (in years)     10.0       10.0  
Expected volatility     76.0%- 136.5 %     115.0 %

Schedule of Stock Option Activity

A summary of performance stock options under our stock incentive plans is detailed in the following table.

 

                Weighted  
                Average  
          Weighted     Remaining  
    Shares     Average     Contractual  
    Underlying     Exercise     Term  
    Options     Price     (In Years)  
Outstanding as of April 30, 2020     81,347     $ 1.05       9.7  
Granted     344,723     $ 2.93          
Exercised     -     $ -          
Cancelled/forfeited     (1,280 )   $ 2.90          
Outstanding as of April 30, 2021     424,790     $ 2.57       9.5  
Exercisable as of April 30, 2021     40,668     $ 1.05       8.7